RSV Monovalent Antigen Vaccine (Sanofi)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RSV Monovalent Antigen Vaccine (Sanofi), covering 2026-04-08 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age [Phase 1]